White Cloud

White Cloud Capital is a growth investment firm based in Luxembourg, founded in 2018. The firm focuses on investing in companies within the healthcare and industrial services sectors, emphasizing technologies that drive innovation in these fields. White Cloud Capital manages a private equity growth expansion fund, which targets various areas including software, healthcare services, healthcare technology systems, big data, and telecommunications. By concentrating on these sectors, White Cloud aims to support businesses that are poised to create significant advancements and improve outcomes in healthcare and related industries.

Nicholas Watkins

Co-Founder, Managing Partner and Board Member

22 past transactions

Conundrum

Series A in 2022
Conundrum Industrial Limited specializes in designing and developing artificial intelligence-based enterprise software tailored for various manufacturing sectors. The company's primary offering, Conundrum AIaaS, provides a platform for users to remotely monitor and control factory operations. This technology addresses critical issues such as predictive maintenance, optimization, and quality control across multiple industries, including chemical production, pulp and paper, oil and gas, steel and mining, and equipment manufacturing. Founded in 2018, Conundrum is headquartered in the United Kingdom, where it focuses on delivering innovative AI solutions to enhance operational efficiency in industrial settings.

Ellipsis Health

Series A in 2021
Ellipsis Health, Inc. is a technology company based in San Francisco, California, that specializes in analytics solutions aimed at enhancing behavioral health. Founded in 2013, the company utilizes artificial intelligence to analyze patient speech and clinical data, enabling the prediction of health and well-being. By developing affective computing tools, Ellipsis Health creates real-time behavioral health metrics for patients, allowing health systems to continuously screen for conditions such as depression. This approach provides a simple and cost-effective method for healthcare providers to identify at-risk patients and ensure they receive the necessary support.

Treos Bio

Convertible Note in 2021
Treos Bio, Inc. develops precision cancer immunotherapies tailored to patients' genetics. The company offers PEPI, a test that uses genetic data obtained from a saliva or blood sample to predict an individual’s antigen specific immune response; PolyPEPI immunotherapy vaccines for melanoma, lung cancer, and breast cancer; and PolyPEPI CDx companion diagnostic test to predict whether a treatment will be effective in a particular patient enabling to tailor vaccines to the DNA of cancer patients. The company was founded in 2013 and is based in San Francisco, California. Treos Bio, Inc. operates as a subsidiary of Treos Bio Limited.

LGN

Seed Round in 2021
LGN Innovations, Inc. specializes in developing artificial intelligence-based perception systems aimed at achieving human-level perception for autonomous systems. Founded in 2018 and headquartered in San Francisco, California, with additional offices in London and Zagreb, the company offers products such as LGN Auto-Calibrate, which integrates AI with sensor arrays, and LGN Intelligent Select, designed to efficiently filter and compress data. LGN's technology enhances the resolution and imaging capabilities of electronic devices, making it applicable across various sectors, including automotive, retail, and satellite industries. By optimizing data capture and processing, LGN's solutions reduce costs and power consumption while enabling high-level autonomy even with lower-cost sensors.

Universal Quantum

Seed Round in 2020
Universal Quantum is building quantum computers to tackle real-world problems that would take today’s fastest supercomputers billions of years to solve.

Oxford VR

Series A in 2020
Oxford VR Limited, founded in 2016 and based in Oxford, United Kingdom, specializes in developing automated cognitive treatments for various clinical conditions, including fear of heights, psychosis, and social anxiety. Originating from research at Oxford University by Professor Daniel Freeman, the company harnesses immersive virtual reality technology to deliver therapy through a virtual coach. This innovative approach aims to significantly increase access to mental health treatments, making them faster, more effective, and lower in cost compared to traditional methods. Oxford VR focuses on creating clinically validated and user-centered therapies that not only benefit patients but also positively impact the healthcare system and the broader economy.

LGN

Funding Round in 2019
LGN Innovations, Inc. specializes in developing artificial intelligence-based perception systems aimed at achieving human-level perception for autonomous systems. Founded in 2018 and headquartered in San Francisco, California, with additional offices in London and Zagreb, the company offers products such as LGN Auto-Calibrate, which integrates AI with sensor arrays, and LGN Intelligent Select, designed to efficiently filter and compress data. LGN's technology enhances the resolution and imaging capabilities of electronic devices, making it applicable across various sectors, including automotive, retail, and satellite industries. By optimizing data capture and processing, LGN's solutions reduce costs and power consumption while enabling high-level autonomy even with lower-cost sensors.

Ellipsis Health

Seed Round in 2019
Ellipsis Health, Inc. is a technology company based in San Francisco, California, that specializes in analytics solutions aimed at enhancing behavioral health. Founded in 2013, the company utilizes artificial intelligence to analyze patient speech and clinical data, enabling the prediction of health and well-being. By developing affective computing tools, Ellipsis Health creates real-time behavioral health metrics for patients, allowing health systems to continuously screen for conditions such as depression. This approach provides a simple and cost-effective method for healthcare providers to identify at-risk patients and ensure they receive the necessary support.

Optellum

Seed Round in 2019
Optellum Ltd, based in Oxford, United Kingdom, specializes in developing AI clinical decision support software focused on lung cancer diagnosis and treatment. Founded in 2015, the company aims to transform cancer care by providing an end-to-end IT platform that facilitates personalized early diagnosis and therapy. Optellum's innovative imaging biomarker is designed to assist clinicians in managing patients at high risk of lung cancer, the most prevalent and deadliest form of cancer. The company's products leverage machine learning algorithms applied to extensive patient datasets, drawing on the collective expertise of numerous doctors. The team at Optellum includes accomplished professionals in medical imaging software, AI, and clinical practice, many of whom have backgrounds in successful startups. Supported by a distinguished Advisory Board of leading clinicians and deep learning experts, Optellum is committed to advancing cancer treatment through technology and innovation.

Astroscreen

Seed Round in 2019
Astroscreen protects brands and defends democracy from harmful social media manipulation campaigns also known as astroturfing.

Hadean

Venture Round in 2019
Hadean Supercomputing Ltd., founded in 2015 and based in London, United Kingdom, is a deep tech company specializing in cloud computing solutions. The company has developed a distributed application platform that allows developers to write and execute code at any scale without the need for complex operations or tuning. Central to Hadean's offerings is HadeanOS, a cloud-native operating system optimized for performance across massively distributed computing infrastructures, which addresses the dynamic scale and real-time demands of modern cloud applications. Additionally, Hadean offers the Aether Engine, a spatial simulation solution designed for game developers, enabling them to exceed traditional technical constraints and achieve unprecedented levels of scale and speed. This innovation allows developers to create cloud-based applications that deliver high fidelity and complexity without sacrificing performance or affordability, ultimately enhancing the gaming experience across various devices and platforms.

Vital Bio

Funding Round in 2019
Vital Biosciences Inc develops tools that helps to monitor health and manage disease. The company was founded in 2016 and is based in Kitchener, Canada.

Synthace

Series B in 2018
Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

BioBeats

Seed Round in 2018
BioBeats Group Ltd designs and develops an online platform BioBeats, that is a machine learning platform that measures biometrics and manages stress and wellness of individuals, employees, and patients in real-time, and helps them action that insight through engaging media. Its application is available for download on Android and iOS devices. The company was incorporated in 2011 and is based in London, United Kingdom.

Facesoft

Seed Round in 2018
FaceSoft is developing machine learning models and databases that improve 3D facial recognition and computer-generated facial reconstruction technologies. The spinout's reconstruction algorithm has been trained on a database of 2.5 million high-resolution 3D facial scans. The company was founded in 2017 and based in London, England.

Beyond

Seed Round in 2018
Beyond Limited operates a platform that enables users to compare funeral director prices, services, and reviews in the United Kingdom. Founded in 2015 and based in London, the company provides various solutions related to end-of-life planning, including arrangements for direct cremation, funeral financing, will writing, and estate settlement. Formerly known as Funeralbooker Ltd, Beyond aims to assist customers in making informed decisions during a difficult time.
Active Global Specialised Caregivers offers home personal care, live-in caregiver, and respite care services. It provides caregiver services for patients with cancer, dementia, diabetes, stroke, heart disease, Parkinson’s disease, visual/hearing impairment, nutrition/elimination problems, schizophrenia, stoma and wound problems, and allergies. Active Global Specialised Caregivers began operation in 2013. It has its headquarters in Singapore.

Synthace

Series A in 2017
Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

Sparrho

Venture Round in 2017
Sparrho is a London-based company that operates a discovery platform for scientific information, designed to make research more accessible. Founded in 2013 by two Oxbridge scientists, the platform combines artificial intelligence with insights from PhD experts to aggregate, distill, and recommend relevant scientific content from a variety of sources, including journals, patents, and conferences. It provides users with customized and filtered recommendations, allowing them to save, share, and disseminate discoveries. Sparrho aims to enhance trust in scientific information and caters to a diverse clientele, including Fortune 500 companies, by delivering real-time, curated updates on the latest research developments.

Hadean

Seed Round in 2017
Hadean Supercomputing Ltd., founded in 2015 and based in London, United Kingdom, is a deep tech company specializing in cloud computing solutions. The company has developed a distributed application platform that allows developers to write and execute code at any scale without the need for complex operations or tuning. Central to Hadean's offerings is HadeanOS, a cloud-native operating system optimized for performance across massively distributed computing infrastructures, which addresses the dynamic scale and real-time demands of modern cloud applications. Additionally, Hadean offers the Aether Engine, a spatial simulation solution designed for game developers, enabling them to exceed traditional technical constraints and achieve unprecedented levels of scale and speed. This innovation allows developers to create cloud-based applications that deliver high fidelity and complexity without sacrificing performance or affordability, ultimately enhancing the gaming experience across various devices and platforms.

Beyond

Pre Seed Round in 2016
Beyond Limited operates a platform that enables users to compare funeral director prices, services, and reviews in the United Kingdom. Founded in 2015 and based in London, the company provides various solutions related to end-of-life planning, including arrangements for direct cremation, funeral financing, will writing, and estate settlement. Formerly known as Funeralbooker Ltd, Beyond aims to assist customers in making informed decisions during a difficult time.

BioBeats

Seed Round in 2016
BioBeats Group Ltd designs and develops an online platform BioBeats, that is a machine learning platform that measures biometrics and manages stress and wellness of individuals, employees, and patients in real-time, and helps them action that insight through engaging media. Its application is available for download on Android and iOS devices. The company was incorporated in 2011 and is based in London, United Kingdom.